Takotsubo syndrome is a sudden, temporary weakening of the heart muscle triggered by intense stress. Often called “broken heart syndrome” or stress cardiomyopathy, it mimics a heart attack with chest pain and shortness of breath, but occurs without the blocked arteries that cause a traditional heart attack. About 90% of cases occur in postmenopausal women, and most people recover full heart function within days.
How Stress Damages the Heart
When you experience extreme stress, your body floods your bloodstream with stress hormones. In takotsubo syndrome, that surge overwhelms the heart muscle, particularly the left ventricle, the chamber responsible for pumping blood to the rest of your body. The tip (apex) of the left ventricle balloons outward and stops contracting properly, while the base of the heart squeezes harder to compensate. On imaging, this gives the heart a distinctive shape resembling a Japanese octopus trap called a “takotsubo,” which is how the condition got its name.
The wall motion abnormalities extend beyond what a single blocked artery could cause, which is one of the key features that separates it from a heart attack. Non-apical variants exist where the ballooning happens in the middle or base of the ventricle instead, though these are less common.
Common Triggers
The name “broken heart syndrome” is somewhat misleading. While emotional distress like grief, intense anger, or shock can trigger it, physical triggers are actually more common. In a large international registry published in the New England Journal of Medicine, physical triggers accounted for 36% of cases compared to 27.7% for emotional ones. Physical triggers include acute illness, surgery, a severe asthma attack, or a neurological event like a seizure. About 7.8% of patients had both emotional and physical triggers at the same time.
Perhaps most surprising: 28.5% of patients developed takotsubo syndrome with no identifiable trigger at all. Emotional triggers were more common in women, while physical triggers were more prevalent in men.
Symptoms That Mimic a Heart Attack
Takotsubo syndrome looks and feels nearly identical to a heart attack. You may experience sudden chest pain, shortness of breath, and weakness. An electrocardiogram will often show abnormal patterns, and blood tests will reveal slightly elevated levels of troponin, a protein the heart releases when it’s injured. The critical difference is that when doctors perform a coronary angiogram (a test that visualizes the heart’s arteries), they find no significant blockages or ruptured plaques.
Because the symptoms overlap so heavily, takotsubo syndrome is almost always diagnosed in a hospital after a suspected heart attack has been ruled out. There is no reliable way to distinguish the two conditions based on symptoms alone.
How It’s Diagnosed
Doctors use a set of criteria, most commonly the modified Mayo Clinic criteria, to confirm a diagnosis. Four conditions need to be met: the heart shows a temporary wall motion abnormality that doesn’t match the territory of a single coronary artery, there’s no obstructive coronary artery disease or evidence of plaque rupture, the ECG shows new changes or troponin levels are elevated, and myocarditis (inflammation of the heart muscle from infection) has been ruled out.
A scoring tool called the InterTAK Diagnostic Score helps doctors estimate the probability of takotsubo versus a traditional heart attack before angiography. It assigns points for factors like female sex (25 points), emotional trigger (24 points), physical trigger (13 points), certain ECG patterns, and a history of psychiatric or neurological disorders. A score of 70 or above suggests a high probability of takotsubo syndrome.
Who Gets It
Postmenopausal women make up roughly 90% of takotsubo cases. The sharp decline in estrogen after menopause is thought to play a role, since estrogen has protective effects on the cardiovascular system and influences how the body responds to stress hormones. Men can develop the condition too, and when they do, the outcomes tend to be worse. One large study found that in-hospital mortality was more than double in men compared to women.
People with a history of psychiatric disorders or neurological conditions also appear to be at higher risk, which is reflected in the diagnostic scoring system giving extra points for these conditions.
Complications and Mortality
Takotsubo syndrome was once considered a benign condition, but that view has changed significantly. In-hospital mortality runs around 6.5%, which is far from trivial. Roughly one in three patients (35.9%) develops congestive heart failure during their hospital stay. Other complications include atrial fibrillation (20.7%), cardiogenic shock (6.6%), cardiac arrest (3.4%), and stroke (5.3%). These numbers make clear that even though the heart muscle typically recovers, the acute phase carries real danger.
Treatment and Recovery
There are no randomized clinical trials establishing a definitive treatment protocol for takotsubo syndrome, so management is based on observational data and expert consensus. In the acute phase, treatment typically mirrors early heart attack care: blood thinners, medications that reduce the heart’s workload, and close monitoring. If heart failure develops, additional medications to manage fluid buildup may be used.
After discharge, patients are generally prescribed blood pressure-lowering medications (ACE inhibitors or similar drugs) along with heart rate-controlling medications. One interesting finding from a meta-analysis: ACE inhibitors appear to reduce the risk of recurrence, while beta-blockers, despite being commonly prescribed, do not seem to prevent it from coming back. Psychological stress management is also recommended as part of long-term care.
The good news is that 96% of patients recover full left ventricular function, with wall motion abnormalities resolving within days. Recurrence is uncommon, reported at about 4% overall, with an annual recurrence rate of 1 to 3%. When takotsubo does come back, it can be triggered by a completely different stressor than the first episode, and recurrent episodes are associated with higher 30-day cardiovascular mortality.